Lighthouse II Trial Phase 3 underway
Update from Dr Alan Stanley, Consultant Neurologist and Principal Investigator for Lighthouse II Phase 3 clinical trial….
Update from Dr Alan Stanley, Consultant Neurologist and Principal Investigator for Lighthouse II Phase 3 clinical trial….
The inaugural webinar in the newly developed MND New Zealand Community Forum series went successfully, with an…
A new set of clinical guidelines for the management and care of individuals with MND has been…
In his inaugural lecture on 17 October 2022, Professor Shaw gave insight to the remarkable progress recently achieved with a…
Join us for this inaugural webinar in the newly developed MND New Zealand Community Forum where leading…
MND New Zealand welcomes the announcement of Professor Chris Shaw in his appointment to the Hugh Green…
By October of this year, a small group of New Zealanders living with Motor Neuron Disease will…
This year’s symposium was held virtually from 9 – 11 December. For further details on the presentations…
In light of the most recent COVID-19 lockdown period, affecting Auckland and now lowering of alert levels…
Results from a study investigating if ‘a lack of social support and perceived stigma contributes to psychological…
To all participants and potential participants in our University of Auckland/ADHB MND genetics screening and MRI scanning…